Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology | Musculoskeletal | Family Medicine
Disease Category: Parkinson's Disease
Location: United States, FL
A Phase III, Multicenter, Randomized, Double-blind, Double-dummy, Active-controlled Study Comparing the Efficacy and Safety of gastric Retentive, Controlled Release Accordion Pill™ Carbidopa/Levodopa (AP-CD/LD) to Immediate Release CD/LD in Fluctuating Parkinson's Disease Patients
This research study will assess the safety, tolerability and effectiveness of Accordion Pill Carbidopa/Levodopa (AP-CD/LD) compared to Immediate Release Carbidopa/Levodopa (IR CD/LD) (Sinemet) in patients with fluctuating Parkinson’s Disease (PD).
CW ID: 214086
Date Last Changed:
April 11, 2016
Leigh DonharlUSF Health Byrd Alzheimer's Institute4001 East Fletcher AvenueTampa, FL 33613Phone: 813 396-0763
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
We value your privacy and your information will only be used by the research center to contact
you regarding this study.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2017 CenterWatch.